Fumi Sato-Kaneko

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer

Fumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi et al. · JCI Insight · 2017 · 287 citations · Full text

Life Sciences, Immunology, Oncology +17

Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release

Jonathan Shpigelman, Fitzgerald S. Lao, Shiyin Yao et al. · Frontiers in Pharmacology · 2021 · 59 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist

Tadashi Hosoya, Fumi Sato-Kaneko, Alast Ahmadi et al. · Proceedings of the National Academy of Sciences · 2018 · 38 citations · Full text

Medicine, Immunology, Oncology +16

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity

Fumi Sato-Kaneko, Shiyin Yao, Fitzgerald S. Lao et al. · Frontiers in Immunology · 2020 · 30 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Identification of Biologically Active Pyrimido[5,4-<i>b</i>]indoles That Prolong NF-κB Activation without Intrinsic Activity

Michael Chan, Alast Ahmadi, Shiyin Yao et al. · ACS Combinatorial Science · 2017 · 18 citations

Life Sciences, Immunology, Pharmacology +17